Re: Resverlogix Announces Conversion of US$12 Million Debenture Strengthening Balance Sheet
posted on
Oct 14, 2020 06:23PM
$1 Billion CAD? LOL
I could swear you were the one who posted this research link: https://seekingalpha.com/article/4314267-real-value-of-breakthrough-therapy-designation
which identifies $8.3 Billlion USD as an average market cap for companies that just received FDA BTD (that average includes lots of orphan, thin markets). We have a safe drug for major conditions and we are currently valued at one-fortieth to one-fiftieth of that basic average market cap.